Loading...

MDWN

MDWD

MEDIWOUND LTD

(MDWD)

2025 6-K

Contract Award Announcement

2 Apr '26

Annual Meeting Notice

30 Mar '26

Financial Results Report

5 Mar '26

Shareholder Meeting Results

19 Feb '26

Extraordinary Meeting Notice

15 Jan '26

Corporate Update

12 Jan '26

Financial Results Update

20 Nov '25

Share Offering Report

30 Sep '25

Share Offering Announcement

29 Sep '25

Insider Share Purchases

19 Aug '25

Q2 Earnings Report

14 Aug '25

Financial Update

21 May '25

Shareholder Meeting Results

15 May '25

Annual Meeting Notice

7 Apr '25

Financial Results Update

19 Mar '25

Clinical Trial Initiation

12 Feb '25

Company Update

8 Jan '25

Shareholder Meeting

19 Dec '24

Board Purchases Shares

16 Dec '24

Quarterly Results

26 Nov '24

Shareholder Meeting Notice

14 Nov '24

FDA Approval Announcement

15 Aug '24

Company Presentation Update

14 Aug '24

Q2 2024 Results

14 Aug '24

Positive Results

5 Aug '24

Funding Announcement

16 Jul '24

Settlement Agreement Update

15 Jul '24

Funding & Collaboration

15 Jul '24

Shareholder Meeting Results

9 Jul '24

Annual Meeting Notice

29 May '24

Financial Report

29 May '24

Financial Report Update

21 Mar '24

Positive Study Results

12 Feb '24

FDA Review Acceptance

9 Jan '24

Company Presentation

8 Jan '24

External Links:

SEC

On September 29, 2025, MediWound Ltd. entered a securities purchase agreement for the sale of 1,734,105 shares at $17.30 each, raising approximately $30 million, with proceeds for pre-commercial activities and manufacturing enhancement. The offering closed on September 30, 2025.

AI Assistant

MEDIWOUND LTD

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.